Abstract:Abstract A biphasic dose response curve was observed when the bone marrow-derived cell line FDCP1, used as an indicator line for IL-3 bioassays, was exposed to supernatants from some activated T cell clones but not others. The active component which inhibited proliferation at the higher supernatant concentrations appeared to be IFN-gamma, based on the following observations. 1) Only those culture supernatants which contained IFN-gamma gave a biphasic dose response curve; 2) with these supernatants, an anti-IFN-gamma mAb augmented the proliferation of FDCP1 cells at the higher supernatant concentrations; and 3) rIFN-gamma profoundly inhibited the proliferation of FDCP1 cells stimulated with rIL-3 or rIL-4. rTNF-alpha inhibited FDCP1 proliferation only to a modest extent, yet the combination of rTNF-alpha + rIFN-gamma provided greater inhibition than each agent alone. The proliferation of a second bone marrow-derived cell line, DA1, was not inhibited by rIFN-gamma or rIFN-gamma + rTNF-alpha when stimulated with rIL-3 or recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF). Fresh bone marrow cells also showed a suboptimal proliferative response when stimulated with T cell supernatants containing IFN-gamma, and this response was augmented considerably upon the addition of anti-IFN-gamma mAb. Bone marrow cell proliferation was observed upon exposure to rIL-3, rIL-4, or rGM-CSF, and these responses were inhibited by rIFN-gamma; rTNF-alpha also produced a synergistic effect with these cells. Bone marrow cell colony formation stimulated by rIL-3 or rGM-CSF also was inhibited by rIFN-gamma. Colony formation in bone marrow cell cultures was not observed in response to rIL-4. Collectively, these results suggest that Th1 cells, which in addition to IL-3 and GM-CSF also produce IFN-gamma, may regulate hemopoietic cell proliferation and colony formation differently from the way Th2 cells do, which do not produce IFN-gamma.

Interferon-alpha-induced inhibition of B16 melanoma cell proliferation: interference with the bFGF autocrine growth circuit

Impact of Interferon-alpha1b (IFN-α1b) on Antitumor Immune Response: An Interpretation of the Promising Therapeutic Effect of IFN-alpha1b on Melanoma

Impact of Interferon-alpha1b (IFN-1b) on Antitumor Immune Response: An Interpretation of the Promising Therapeutic Effect of IFN-alpha1b on Melanoma

Effects of IFN-α1b on the Proliferation, Migration and Apoptosis of Melanoma Cell A375

Modulation of Gene Expression in MHCC97 Cells by Interferon Alpha

Effect of Interferon-Gamma on the Expression of Basic Fibroblast Growth Factor on Hep-2 Laryngeal Carcinoma Cell Lines

Interferon Gamma Inhibits CXCL8-Induced Proliferation and Migration of Pancreatic Cancer BxPC-3 Cell Line Via a RhoGDI2/Rac1/NF-κB Signaling Pathway.

alpha-Interferon down-regulates epidermal growth factor receptors on renal carcinoma cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon

[Study on the Biological Activity and Molecular Mechanism of IFNalpha on Human Myeloma Cell Line Sko-007].

Interferon Alpha 2a Downregulates Vegf Expression Through Pi3 Kinase and Map Kinase Signaling Pathways

Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma

Monoclonal Antibodies Targeting Basic Fibroblast Growth Factor Inhibit the Growth of B16 Melanoma in Vivo and in Vitro.

In vitro effect of interferon alpha on proliferation of human marrow fibroblast]

Gamma-Interferon in Multiple Myeloma: Inhibition of Interleukin-6 (Il-6)-dependent Myeloma Cell Growth and Downregulation of IL-6-receptor Expression in Vitro.

IFNg-induced Irgm1 promotes tumorigenesis of melanoma via dual regulation of apoptosis and Bif-1-dependent autophagy

Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.

Inhibition effects of bFGF mAb and cisplatin on proliferation of melanoma B16 cells in vitro

Interferon-gamma signaling promotes melanoma progression and metastasis

Basic Fibroblast Growth Factor Affects the Expression of Angiogenin and Cell Proliferation in A375 Human Melanoma Cells

Inhibition of Tumor Angiogenesis by Interferon-Γ by Suppression of Tumor-Associated Macrophage Differentiation.

Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells.